Suzanne Berlin
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 25
- Pharmacology top 2%
- Toxicology top 5%
- Immunology and Allergy top 5%
- Dermatology top 5%
-
- Renal cell carcinoma treatment 7
-
- Endometrial and Cervical Cancer Treatments 5
-
- Cancer Treatment and Pharmacology 4
-
- Cancer Mechanisms and Therapy 3
-
- Reproductive Biology and Fertility 3
-
- Cancer, Lipids, and Metabolism 3
-
- Angiogenesis and VEGF in Cancer 3
Suzanne Berlin
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 77
- Reproductive Medicine 451
- Pharmacology 378
- Toxicology 69
- Immunology and Allergy 101
- Dermatology 143
Countries citing papers authored by Suzanne Berlin
This map shows the geographic impact of Suzanne Berlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Berlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Berlin more than expected).
Fields of papers citing papers by Suzanne Berlin
This network shows the impact of papers produced by Suzanne Berlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Berlin. The network helps show where Suzanne Berlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Suzanne Berlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2020 | 16 | |
| 3 | 2015 | 86 | |
| 4 | 2015 | 42 | |
| 5 | 2015 | 8 | |
| 6 | 2013 | 17 | |
| 7 | 2013 | 4 | |
| 8 | 2013 | 17 | |
| 9 | 2013 | 85 | |
| 10 | 2013 | 8 | |
| 11 | 2012 | 41 | |
| 12 | 2012 | 13 | |
| 13 | 2012 | 13 | |
| 14 | 2011 | 17 | |
| 15 | 2011 | 16 | |
| 16 | 2010 | 61 | |
| 17 | 2010 | 4 | |
| 18 | 2009 | 8 | |
| 19 | 2008 | 408 | |
| 20 | Phase II study of Cediranib (RECENTIN™, AZD2171) in recurrent epithelial ovarian cancer | 2007 | 1 |
About Suzanne Berlin
Suzanne Berlin is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (25 papers), Renal cell carcinoma treatment (7 papers), Endometrial and Cervical Cancer Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Mechanisms and Therapy (3 papers), Reproductive Biology and Fertility (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Reproductive Medicine (451 citations), Pharmacology (378 citations), Toxicology (69 citations), Immunology and Allergy (101 citations) and Dermatology (143 citations). Suzanne Berlin has collaborated with scholars based in United States and Israel. Frequent co-authors include Ursula A. Matulonis, Susana M. Campos, Richard T. Penson, Mariana Castells, Neil S. Horowitz, Carolyn Krasner, Maria Roche, Hang Lee, David I. Hong and David E. E. Sloane. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Healthcare, Journal of Allergy and Clinical Immunology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.